ASP Isotopes vs Bon Natural Life
ASP Isotopes is the larger business, with $23.8m of revenue in fiscal 2025 against $18.7m for Bon Natural Life (1.3 times as much). ASP Isotopes grew faster (475.5% against -21.7%). Bon Natural Life kept more of each dollar of sales as profit: a net margin of -10.7% against -670.2%.
| Latest fiscal year | ASP IsotopesASPI, 2025 | Bon Natural LifeBON, 2025 |
|---|---|---|
| Revenue | $23.8m | $18.7m |
| Revenue growth | 475.5% | -21.7% |
| Net income | −$160m | −$2.0m |
| Operating margin | — | -8.7% |
| Net margin | -670.2% | -10.7% |
| Return on equity | -126.8% | -3.9% |
| Free cash flow | −$47.4m | $134,288 |
| Cash | $280m | $6.3m |
| Total debt | $200m | $12.2m |
| Debt to equity | — | 21.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 271 | — |
| Market value | $235m | $3.1m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 2 buys, 30 sales | 0 buys, 0 sales |